Design and development of hydrogel beads for targeted drug delivery to the colon
The purpose of this research was to develop and evaluate a multiparticulate system of chitosan hydrogel beads exploiting pH-sensitive property and specific biodegradability for colon-targeted delivery of satranidazole. Chitosan hydrogel beads were prepared by the cross-linking method followed by enteric coating with Eudragit S100. All formulations were evaluated for particle size, encapsulation efficiency, swellability, and in vitro drug release. The size of the beads was found to range from 1.04±0.82 mm to 1.95±0.05 mm. The amount of the drug released after 24 hours from the formulation was found to be 97.67%±1.25% in the presence of extracellular enzymes as compared with 64.71%±1.91% and 96.52%±1.81% release of drug after 3 and 6 days of enzyme induction, respectively, in the presence of 4% cecal content. Degradation of the chitosan hydrogel beads in the presence of extracellular enzymes as compared with rat cecal and colonic enzymes indicates the potential of this multiparticulate system to serve as a carrier to deliver macromolecules specifically to the colon and can be offered as a substitute in vitro system for performing degradation studies. Studies demonstrated that orally administered chitosan hydrogel beads can be used effectively for the delivery of drug to the colon.
KeywordsChitosan pH-sensitive polymer colon-specific drug delivery hydrogel beads multiparticulate system satranidazole
Davis SS. Assessment of gastrointestinal transit and drug absorption. In: Prescott LF, Nimmo WS, eds.Novel Drug Delivery and Its Therapeutic Application
. Chichester, UK: Wiley; 1990:89–101.Google Scholar
Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems.J Pharm Pharm Sci.
Davaran S, Hanaee J, Khosravi A. Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery.J Control Release
. 1999:58:279–287.CrossRefGoogle Scholar
Schacht E, Gevaert A, Kenawy ER, et al. Polymers for colon specific drug delivery.J Control Release
. 1996;39:327–338.CrossRefGoogle Scholar
Chung KT, Stevens SE, Cerniglia CE. The reduction of azo dyes by the intestinal microflora.Crit Rev Microbiol.
Yamaoka T, Makita Y, Sasatani H, Kim SI, Kimura Y. Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: its properties degradation behavior and utilization for drug formulation.J Control Release
. 2000;66:187–197.CrossRefGoogle Scholar
Shantha KL, Ravichandran P, Rao KP. Azo polymeric hydrogels for colon targeted drug delivery.Biomaterials
. 1995;16:1313–1318.CrossRefGoogle Scholar
Van den Mooter G, Samyn C, Kinget R. Azo, polymers for colon-specific drug delivery.Int J Pharm.
Jain A, Gupta Y, Jain SK. Azo-chemistry and its potential for colonic delivery.Crit Rev Ther Drug Carrier Syst.
Ghandehari H, Kopeckova P, Kopecek J.In vitro
-degradation of pH sensitive hydrogels containing aromatic azo bonds.Biomaterials
. 1997;18:861–872.CrossRefGoogle Scholar
Kakoulides EP, Smart JD, Tsibouklis J. Azocrosslinked poly(acrylic acid) for colonic delivery and adhesion specificity synthesis and characterization.J Control Release
. 1998;52:291–300.CrossRefGoogle Scholar
Chaurasia M, Chourasia MK, Jain NK, et al. Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer.AAPS PharmSciTech.
2006;7:Article 74.CrossRefGoogle Scholar
Shimono N, Takatori T, Masumi T, et al. Chitosan dispersed system for colon-specific drug delivery.Int J Pharm.
Tozaki H, Komoike J, Tada C, et al. Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon.J Pharm Sci.
Jain A, Gupta Y, Jain SK. Potential of calcium pectinate beads for target specific drug release to colon.J Drug Target
. 2007;15:285–294.CrossRefGoogle Scholar
Rubinstein A. Microbially controlled drug delivery to the colon.Biopharm Drug Dispos.
Ashford M, Fell JT, Attwood D, Sharma H, Woodhead P. Anin vivo
investigation into the suitability of pH-dependent polymers for colonic targeting.Int J Pharm.
Furda I. Aminopolysaccharides—their potential as dietary fiber. In: Furda I, ed.Unconventional Sources of Dietary Fiber, Physiological and In vitro Functional Properties
. Washington, DC: American Chemical Society; 1983:105–122.Google Scholar
Ormrod DJ, Holmes CC, Miller TE. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis.Atherosclerosis
. 1998;138: 329–334.CrossRefGoogle Scholar
Yamamoto A, Tozaki H, Okada N, Fujita T. Colon specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules.STP Pharma Sciences
. 2000;10:23–43.Google Scholar
Tozaki H, Odoriba T, Okada N, et al. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.J Control Release
. 2002;82:51–61.CrossRefGoogle Scholar
Fernandez-Hervas MJ, Fell JT. Pectin/chitosan mixtures as coatings for colon-specific drug delivery: anin vitro
evaluation.Int J Pharm.
Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine.Gut.
Zhang H, Ibrahim A, Alsarra S, Neau H. An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.Int J Pharm.
Huyghebaert N, Vermeire A, Remon JP, In vitro evaluation of coating polymers for enteric coating and human ileal targeting.Int J Pharm.
Prizont R, Konigsberg N. Identification of bacterial glycosidases in rat caecal contents.Dig Dis Sci.
Mason VC. Some observations on the distribution and origin of nitrogen in sheep feces.J Agric Sci.
Salyers AA, Palmer JK, Wilkins TD. Degradation of polysaccharides by intestinal bacterial enzymes.Am J Clin Nutr.
Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon.Drug Deliv.
Sezer AD, Akbuga J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads.J Microencapsul.
© American Association of Pharmaceutical Scientists 2007